Two-step workflow could reshape Alzheimer’s detection in primary care A recent study published in Nature Medicine proposes a practical, scalable approach to diagnosing Alzheimer’s disease (AD) in everyday clinics: first confirm cognitive impairment with a brief digital tool, then use a targeted blood biomarker panel to verify amyloid pathology. This “test then blood” strategy aims…